661. Vagus nerve stimulation reduces suicidal ideation in markedly treatment-resistant depression: RECOVER findings
A J Rush, V Hristidis, V De Leon, A Van Der Vaart et autres
0 citationsThe International Journal of Neuropsychopharmacology
LivaNova (United Kingdom)
London · GB · company
173Publications signalées
9260Citations signalées
12Thèmes principaux
Principaux domaines
Vagus Nerve Stimulation ResearchNeurological disorders and treatmentsNicotinic Acetylcholine Receptors StudyMedical Imaging Techniques and ApplicationsEpilepsy research and treatmentAdvanced MRI Techniques and ApplicationsNeurotransmitter Receptor Influence on BehaviorAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsMultiple Sclerosis Research StudiesBotulinum Toxin and Related Neurological DisordersCardiac pacing and defibrillation studies
Évolution annuelle
Publications récentes
655. Toward a brief, sensitive tool to assess depressive symptom outcomes in research and clinical practice: lessons from the RECOVER trial
A J Rush, H Sackeim, Y-C Lee, C Conway et autres
0 citationsThe International Journal of Neuropsychopharmacology
The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions
Charles R. Conway, Harold A. Sackeïm, A. John Rush, Mark Bunker et autres
0 citationsAmerican Journal of Psychiatry
The extent and durability of improvement in depressive symptoms, quality of life, and daily function with three years of vagus nerve stimulation in markedly treatment-resistant depression: A RECOVER study report
Charles R. Conway, Scott T. Aaronson, A. John Rush, Ying-Chieh Lee et autres
0 citationsmedRxiv
A Systems Pharmacology Model of Aging Identifies Optimal Combination Therapies With Secondary Benefits on Weight Loss and Metabolic Health
Igor Goryanin, Bob Damms, Irina Goryanin
0 citationsCPT Pharmacometrics & Systems Pharmacology
Impact of Vagus Nerve Stimulation on Suicidal Ideation in Markedly Treatment-Resistant Major Depression
Vasilis Hristidis, Victoria de Leon, Andrew D. van der Vaart, Harold A. Sackeïm et autres
0 citationsThe Journal of Clinical Psychiatry
EHMN2026®T: A License-Aware AI-QSP Integration Framework Linking EHMN2026® with TRANSFAC®, TRANSPATH® and HumanPSD™ for Diagnostic-Metabolite Interpretation
Igor Goryanin, Leonid Slovianov, Irina V. Goryanin, Alexander Kel
0 citationsMetabolites
Validation of AI-enabled surrogate models in quantitative systems pharmacology: a practical, context-of-use-driven review
0 citationsDrug Discovery Today
Thermophysiological BioEnergy Index as a Biomarker of Biological Ageing: A Large-Scale Microwave Radiometry Study
Igor Goryanin, Illarion Popov, А. В. Тараканов, Sergey Vesnin et autres
0 citationsDiagnostics
Effectiveness and safety of implantable vagus nerve stimulation in people with primary generalized tonic–clonic seizures
Katherine Eggleston, Justine Curley, Ryan Verner, Maxine Dibué et autres
1 citationEpilepsia Open
D97-09 False Positive Responses in Hypoglossal Nerve Stimulation Clinical Trials
A R Schwartz, O Jacobowitz, C Gordon, R van Poelgeest et autres
0 citationsAmerican Journal of Respiratory and Critical Care Medicine
VNS Therapy is Associated with Reduced Severe Disabling Seizure Burden in Children Early in Treatment (3 Months) of DRE with Continued Improvement Over 36 Months
S. Fetzer, M. Dibué, A. Sen, A. Core Vns Registry Group
0 citationsNeuropediatrics
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.